Concepts (97)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tomography, X-Ray Computed | 12 | 2018 | 85 | 2.330 |
Why?
|
| Positron-Emission Tomography | 10 | 2012 | 15 | 1.780 |
Why?
|
| Fluorodeoxyglucose F18 | 8 | 2012 | 11 | 1.510 |
Why?
|
| Multimodal Imaging | 4 | 2012 | 4 | 0.880 |
Why?
|
| Sarcoma | 3 | 2011 | 3 | 0.750 |
Why?
|
| Bone Neoplasms | 3 | 2011 | 14 | 0.740 |
Why?
|
| Lung Neoplasms | 4 | 2011 | 25 | 0.710 |
Why?
|
| Humans | 18 | 2018 | 2957 | 0.700 |
Why?
|
| Paranasal Sinus Neoplasms | 1 | 2018 | 3 | 0.550 |
Why?
|
| Osteoblastoma | 1 | 2018 | 3 | 0.550 |
Why?
|
| Female | 9 | 2018 | 1724 | 0.500 |
Why?
|
| Arachnoid Cysts | 1 | 2016 | 2 | 0.490 |
Why?
|
| Growth Plate | 1 | 2016 | 2 | 0.490 |
Why?
|
| Back Pain | 1 | 2016 | 2 | 0.490 |
Why?
|
| Spine | 1 | 2016 | 3 | 0.490 |
Why?
|
| Arabinonucleosides | 1 | 2016 | 2 | 0.470 |
Why?
|
| Spinal Cord Diseases | 1 | 2016 | 2 | 0.470 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2016 | 3 | 0.470 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 16 | 0.470 |
Why?
|
| Radiopharmaceuticals | 4 | 2015 | 11 | 0.450 |
Why?
|
| Fluorine Radioisotopes | 1 | 2011 | 1 | 0.350 |
Why?
|
| Myositis Ossificans | 1 | 2011 | 1 | 0.350 |
Why?
|
| Radiation Injuries | 1 | 2011 | 1 | 0.350 |
Why?
|
| Fractures, Stress | 1 | 2011 | 1 | 0.350 |
Why?
|
| Pelvis | 1 | 2011 | 3 | 0.350 |
Why?
|
| Bronchial Diseases | 1 | 2011 | 1 | 0.340 |
Why?
|
| Bronchial Neoplasms | 1 | 2011 | 1 | 0.340 |
Why?
|
| Granuloma, Plasma Cell | 1 | 2011 | 1 | 0.340 |
Why?
|
| Catheter Ablation | 1 | 2011 | 1 | 0.330 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2011 | 2 | 0.330 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2011 | 2 | 0.330 |
Why?
|
| Liver Neoplasms | 1 | 2011 | 4 | 0.330 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2011 | 4 | 0.330 |
Why?
|
| Aorta | 1 | 2011 | 2 | 0.330 |
Why?
|
| Lymph Nodes | 1 | 2011 | 5 | 0.330 |
Why?
|
| Diagnosis, Differential | 4 | 2018 | 33 | 0.320 |
Why?
|
| Neoplasm Metastasis | 2 | 2010 | 4 | 0.310 |
Why?
|
| Muscle Neoplasms | 1 | 2008 | 1 | 0.290 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2008 | 15 | 0.280 |
Why?
|
| Male | 8 | 2018 | 1860 | 0.250 |
Why?
|
| Adolescent | 2 | 2018 | 247 | 0.240 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2016 | 77 | 0.240 |
Why?
|
| Adult | 5 | 2016 | 794 | 0.210 |
Why?
|
| Whole Body Imaging | 3 | 2012 | 3 | 0.200 |
Why?
|
| Young Adult | 3 | 2018 | 187 | 0.180 |
Why?
|
| Osteoma | 1 | 2018 | 3 | 0.140 |
Why?
|
| Fibroma, Ossifying | 1 | 2018 | 3 | 0.140 |
Why?
|
| Paranasal Sinuses | 1 | 2018 | 4 | 0.140 |
Why?
|
| Preoperative Period | 1 | 2018 | 5 | 0.140 |
Why?
|
| Endoscopy | 1 | 2018 | 5 | 0.140 |
Why?
|
| Middle Aged | 4 | 2015 | 792 | 0.130 |
Why?
|
| Treatment Outcome | 1 | 2018 | 186 | 0.130 |
Why?
|
| Syringomyelia | 1 | 2016 | 2 | 0.120 |
Why?
|
| Arachnoid | 1 | 2016 | 4 | 0.120 |
Why?
|
| Radionuclide Imaging | 1 | 2016 | 8 | 0.120 |
Why?
|
| Neuroimaging | 1 | 2016 | 7 | 0.120 |
Why?
|
| Sphenoid Sinus | 1 | 2015 | 3 | 0.110 |
Why?
|
| Central Nervous System Cysts | 1 | 2015 | 3 | 0.110 |
Why?
|
| Technetium | 1 | 2015 | 2 | 0.110 |
Why?
|
| Myocardial Perfusion Imaging | 1 | 2015 | 2 | 0.110 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2015 | 9 | 0.110 |
Why?
|
| Coronary Artery Disease | 1 | 2015 | 7 | 0.110 |
Why?
|
| United States | 1 | 2016 | 243 | 0.110 |
Why?
|
| Aged | 2 | 2015 | 956 | 0.090 |
Why?
|
| Chondrocalcinosis | 1 | 2012 | 1 | 0.090 |
Why?
|
| Joints | 1 | 2012 | 15 | 0.090 |
Why?
|
| Sacroiliac Joint | 1 | 2011 | 2 | 0.090 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2011 | 3 | 0.080 |
Why?
|
| Lymphatic Metastasis | 1 | 2011 | 3 | 0.080 |
Why?
|
| Child | 1 | 2011 | 197 | 0.080 |
Why?
|
| Histiocytoma, Benign Fibrous | 1 | 2010 | 1 | 0.080 |
Why?
|
| Carcinoma, Merkel Cell | 1 | 2010 | 1 | 0.080 |
Why?
|
| Skin Neoplasms | 1 | 2010 | 5 | 0.080 |
Why?
|
| Kidney Neoplasms | 1 | 2010 | 9 | 0.080 |
Why?
|
| Hemangiopericytoma | 1 | 2010 | 1 | 0.080 |
Why?
|
| Brain Neoplasms | 1 | 2010 | 4 | 0.080 |
Why?
|
| Femoral Vein | 1 | 2009 | 1 | 0.080 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2009 | 2 | 0.080 |
Why?
|
| Pulmonary Artery | 1 | 2009 | 3 | 0.080 |
Why?
|
| Osteosarcoma | 1 | 2009 | 7 | 0.080 |
Why?
|
| Purines | 1 | 2015 | 2 | 0.030 |
Why?
|
| Myocardial Ischemia | 1 | 2015 | 2 | 0.030 |
Why?
|
| Pattern Recognition, Automated | 1 | 2015 | 4 | 0.030 |
Why?
|
| Coronary Angiography | 1 | 2015 | 8 | 0.030 |
Why?
|
| Exercise Test | 1 | 2015 | 6 | 0.030 |
Why?
|
| Pyrazoles | 1 | 2015 | 4 | 0.030 |
Why?
|
| Rest | 1 | 2015 | 8 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2015 | 17 | 0.030 |
Why?
|
| ROC Curve | 1 | 2015 | 20 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2015 | 27 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2015 | 24 | 0.030 |
Why?
|
| Prevalence | 1 | 2015 | 39 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 83 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2015 | 233 | 0.030 |
Why?
|
| Technetium Tc 99m Medronate | 1 | 2012 | 2 | 0.020 |
Why?
|
| Bone and Bones | 1 | 2012 | 69 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2010 | 147 | 0.020 |
Why?
|